Flupentixol

Flupentixol

Form: Tablets

Strength: 0.5 mg, 1 mg, 3 mg

Reference Brands: Fluanxol, Depixol(EU)

Category: Antipsychotropic Drugs

Flupentixol is a typical antipsychotic drug commonly used in Europe to treat schizophrenia and depressive disorders. It is available in oral tablet form (0.5 mg, 1 mg, and 3 mg) and as a long-acting intramuscular injection (Flupentixol decanoate 20 mg/mL and 40 mg/mL). Marketed under brand names such as Fluanxol and Depixol, it is widely prescribed in EU countries, including the UK, Germany, and Scandinavia. Although not approved in the US, Flupentixol remains a critical neuroleptic in the global pharma supply chain. It is in demand among B2B pharmaceutical distributors for mental health and psychiatric care therapies.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Risperidone Long-Acting Injection

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes

Form: Long-Acting Injection

Reference Brands: Risperdal Consta(US &EU)

View Details Get Enquiry
Zuclopenthixol ong-acting IM Injection (Depot)

Strength: 200 mg/mL, 500 mg/mL

Form: Long-acting IM Injection (Depot)

Reference Brands: Clopixol Depot®(US)

View Details Get Enquiry
Zuclopenthixol Short-acting Intramuscular Injection

Strength: 50 mg/mL

Form: Short-acting Intramuscular Injection

Reference Brands: Clopixol-Acuphase®

View Details Get Enquiry
Zuclopenthixol tablets

Strength: 10 mg, 25 mg, 40 mg

Form: Oral Tablets

Reference Brands: Clopixol®(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience on our website. Learn more